80 related articles for article (PubMed ID: 24321784)
1. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.
Falchook AD; Salloum RG; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784
[TBL] [Abstract][Full Text] [Related]
2. Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
Falagario UG; Martini A; Wajswol E; Treacy PJ; Ratnani P; Jambor I; Anastos H; Lewis S; Haines K; Cormio L; Carrieri G; Rastinehad AR; Wiklund P; Tewari A
Eur Urol Oncol; 2020 Oct; 3(5):700-704. PubMed ID: 31548130
[TBL] [Abstract][Full Text] [Related]
3. Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study.
Johnston AW; Longo TA; Davis LG; Zapata D; Freedland SJ; Routh JC
Int Braz J Urol; 2020; 46(1):42-52. PubMed ID: 31851457
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
5. Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
Deniffel D; Healy GM; Dong X; Ghai S; Salinas-Miranda E; Fleshner N; Hamilton R; Kulkarni G; Toi A; van der Kwast T; Zlotta A; Finelli A; Perlis N; Haider MA
Radiology; 2021 Aug; 300(2):369-379. PubMed ID: 34032510
[TBL] [Abstract][Full Text] [Related]
6. A national intervention to reduce imaging for low back pain by general practitioners: a retrospective economic program evaluation using Medicare Benefits Schedule data.
Morgan T; Wu J; Ovchinikova L; Lindner R; Blogg S; Moorin R
BMC Health Serv Res; 2019 Dec; 19(1):983. PubMed ID: 31864352
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
Chen B; Wei P; Macapinlac HA; Lu Y
Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.
Liu D; Kuai Y; Zhu R; Zhou C; Tao Y; Han W; Chen Q
Sci Rep; 2020 Jun; 10(1):9104. PubMed ID: 32499554
[TBL] [Abstract][Full Text] [Related]
9. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.
Makarov DV; Soulos PR; Gold HT; Yu JB; Sen S; Ross JS; Gross CP
JAMA Oncol; 2015 May; 1(2):185-94. PubMed ID: 26181021
[TBL] [Abstract][Full Text] [Related]
10. Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.
Onukwugha E; Kwok Y; Ciezki JP; Yong C; Plaisant C; Reddy CA; Mullins CD; Seal B; Valderrama A; Hussain A
PLoS One; 2017; 12(4):e0175956. PubMed ID: 28419139
[TBL] [Abstract][Full Text] [Related]
11. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.
Leapman MS; Wang R; Loeb S; Seibert TM; Gaylis FD; Lowentritt B; Brown GA; Chen R; Lin D; Witte J; Cooperberg MR; Catalona WJ; Gross CP; Ma X
J Urol; 2023 Apr; 209(4):710-718. PubMed ID: 36753746
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging.
Makarov DV; Loeb S; Ulmert D; Drevin L; Lambe M; Stattin P
J Natl Cancer Inst; 2013 Sep; 105(17):1306-13. PubMed ID: 23853055
[TBL] [Abstract][Full Text] [Related]
13. Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
Gaffney CD; Cai P; Li D; Margolis D; Sedrakyan A; Hu JC; Shoag J
AJR Am J Roentgenol; 2021 Aug; 217(2):389-394. PubMed ID: 34161136
[No Abstract] [Full Text] [Related]
14. Patterns of surveillance imaging after nephrectomy in the Medicare population.
Feuerstein MA; Atoria CL; Pinheiro LC; Huang WC; Russo P; Elkin EB
BJU Int; 2016 Feb; 117(2):280-6. PubMed ID: 25382743
[TBL] [Abstract][Full Text] [Related]
15. Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer.
Mustaffa A; Emara S
Prostate; 2023 Jan; 83(1):128-131. PubMed ID: 36176053
[TBL] [Abstract][Full Text] [Related]
16. Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups.
Sevcenco S; Grubmüller B; Sonneck-Koenne C; Ahmadi Y; Knoll P; Floth A; Pokieser W; Zandieh S; Christoph Klingler H; Shariat S; Mirzaei S
Asia Ocean J Nucl Med Biol; 2019; 7(2):149-152. PubMed ID: 31380454
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Care for Medicare Beneficiaries With Metastatic Prostate Cancer.
Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
[TBL] [Abstract][Full Text] [Related]
18. The cost, survival, and quality-of-life implications of guideline-discordant imaging for prostate cancer.
Winn AN; Kelly M; Ciprut S; Walter D; Gold HT; Zeliadt SB; Sherman SE; Makarov DV
Cancer Rep (Hoboken); 2022 Feb; 5(2):e1468. PubMed ID: 34137520
[TBL] [Abstract][Full Text] [Related]
19. The Cost of Metastatic Prostate Cancer in the United States.
Olsen TA; Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2023 Jan; 10(1):41-47. PubMed ID: 37103444
[TBL] [Abstract][Full Text] [Related]
20. Response evaluation of bone metastasis in prostate cancer: Preliminary comparison of computerized bone scan index versus standardized clinical criteria.
Petersen LJ; Gade M; Fonager RF; Albertsen S; Fledelius J; Ejlersen JA; Christensen MH; Aleksyniene R; Zacho HD
Hell J Nucl Med; 2021; 24(1):2-9. PubMed ID: 33866333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]